计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab183323-100μg |
100μg |
现货 ![]() |
| |
| Ab183323-1mg |
1mg |
现货 ![]() |
| |
| Ab183323-5mg |
5mg |
现货 ![]() |
| |
| Ab183323-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | Pinatuzumab vedotin (anti-CD22), CD22 结合剂的结合剂 |
|---|---|
| 别名 | 维汀-匹那妥珠单抗 | 维汀-匹那妥珠单抗 | 皮那珠单抗维多汀(抗 CD22) |
| 英文别名 | B cell receptor CD22 precursor antibody | B lymphocyte cell adhesion molecule antibody | B-cell receptor CD22 antibody | B-lymphocyte cell adhesion molecule antibody | BL CAM antibody | BL-CAM antibody | BLCAM antibody | CD 22 antibody | CD22 antibody | C |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥90%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | CD22 |
| 种属反应性 | 人(Human),大鼠(Rat),食蟹猴(Cynomolgus monkey) |
| 偶联 | MC-VC-PAB-MMAE |
| 作用类型 | 结合剂 |
| 作用机制 | CD22 结合剂的结合剂 |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | kappa |
| SDS-PAGE | 151.97 kDa |
| 纯化方法 | Protein A purified |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 1313706-14-7 |
| 分子类型 | 抗体偶联药物 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
Pinatuzumab vedotin (anti-CD22) (Ab183323) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD22 with Pinatuzumab vedotin (anti-CD22) (Ab183323) conjugated with biotin (right panel) compared with Human IgG (Biotin) (Ab180314) - Isotype Control (left panel) and detected with SA-PE (rp156150).
Pinatuzumab vedotin (anti-CD22) (Ab183323) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD22 (red) with Pinatuzumab vedotin (anti-CD22) (Ab183323) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, Human IgG (Biotin) (Ab180314). Black - Unlabelled control, cells without incubation with primary antibody.
Pinatuzumab vedotin (anti-CD22) (Ab183323) - Flow Cytometry
Flow Cytometry analysis of Raji cells labelling CD22 (red) with Pinatuzumab vedotin (anti-CD22) (Ab183323). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Pinatuzumab vedotin (anti-CD22) (Ab183323) - ELISA
Immobilized Recombinant Human Siglec-2/CD22 protein (rp169575) at 1.0 μg/mL can bind Pinatuzumab vedotin (anti-CD22) (Ab183323) with the EC50 of 73.42 ng/mL.
Pinatuzumab vedotin (anti-CD22) (Ab183323) - SEC
The purity of Pinatuzumab vedotin (anti-CD22) (Ab183323) is more than 95% verified by HPLC.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab183323 | |
| 分析证书 | Ab183323 | |
| 分析证书 | Ab183323 |